BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36291168)

  • 1. Predicting Progression of Autosomal Dominant Polycystic Kidney Disease by Changes in the Telomeric Epigenome.
    Kocyigit I; Taheri S; Uysal C; Memis M; Ozayturk SG; Zararsiz G; Rassoulzadegan M
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive PKD1 and PKD2 Mutation Analysis in Prenatal Autosomal Dominant Polycystic Kidney Disease.
    Audrézet MP; Corbiere C; Lebbah S; Morinière V; Broux F; Louillet F; Fischbach M; Zaloszyc A; Cloarec S; Merieau E; Baudouin V; Deschênes G; Roussey G; Maestri S; Visconti C; Boyer O; Abel C; Lahoche A; Randrianaivo H; Bessenay L; Mekahli D; Ouertani I; Decramer S; Ryckenwaert A; Cornec-Le Gall E; Salomon R; Ferec C; Heidet L
    J Am Soc Nephrol; 2016 Mar; 27(3):722-9. PubMed ID: 26139440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased amounts and stability of telomeric repeat-containing RNA (TERRA) following DNA damage induced by etoposide.
    Oh BK; Choi Y; Bae J; Lee WM; Hoh JK; Choi JS
    PLoS One; 2019; 14(11):e0225302. PubMed ID: 31756221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA
    Aboudehen K; Farahani S; Kanchwala M; Chan SC; Avdulov S; Mickelson A; Lee D; Gearhart MD; Patel V; Xing C; Igarashi P
    J Biol Chem; 2018 Jun; 293(24):9388-9398. PubMed ID: 29716997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
    Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
    Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.
    Reiterová J; Štekrová J; Merta M; Kotlas J; Elišáková V; Lněnička P; Korabečná M; Kohoutová M; Tesař V
    BMC Nephrol; 2013 Mar; 14():59. PubMed ID: 23496908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAD51-dependent recruitment of TERRA lncRNA to telomeres through R-loops.
    Feretzaki M; Pospisilova M; Valador Fernandes R; Lunardi T; Krejci L; Lingner J
    Nature; 2020 Nov; 587(7833):303-308. PubMed ID: 33057192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomeric noncoding RNA: telomeric repeat-containing RNA in telomere biology.
    Cusanelli E; Chartrand P
    Wiley Interdiscip Rev RNA; 2014; 5(3):407-19. PubMed ID: 24523222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomeric repeat-containing RNA TERRA: a noncoding RNA connecting telomere biology to genome integrity.
    Cusanelli E; Chartrand P
    Front Genet; 2015; 6():143. PubMed ID: 25926849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
    Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
    BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Scale Single Nucleotide Resolution Analysis of DNA Methylation in Human Autosomal Dominant Polycystic Kidney Disease.
    Bowden SA; Rodger EJ; Bates M; Chatterjee A; Eccles MR; Stayner C
    Am J Nephrol; 2018; 48(6):415-424. PubMed ID: 30463078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Endometrial Carcinogenesis Is Associated with Significant Reduction in Long Non-Coding RNA, TERRA.
    Adishesh M; Alnafakh R; Baird DM; Jones RE; Simon S; Button L; Kamal AM; Kirwan J; DeCruze SB; Drury J; Saretzki G; Hapangama DK
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
    Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
    Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bialleleic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families.
    Al-Hamed MH; Alsahan N; Rice SJ; Edwards N; Nooreddeen E; Alotaibi M; Kurdi W; Alnemer M; Altaleb N; Ali W; Al-Numair N; Almejaish N; Sayer JA; Imtiaz F
    Pediatr Nephrol; 2019 Sep; 34(9):1615-1623. PubMed ID: 31079206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
    Hoefele J; Mayer K; Scholz M; Klein HG
    Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney disease.
    Saravanabavan S; Rangan GK
    Nephrology (Carlton); 2021 Nov; 26(11):920-930. PubMed ID: 34331378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
    Wu G
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of targeted sequence capture and high-throughput sequencing identifies a novel PKD1 mutation involved in adult polycystic kidney disease.
    Sha YK; Sha YW; Mei LB; Huang XJ; Wang X; Lin SB; Li L; Li P
    Gene; 2017 Nov; 634():1-4. PubMed ID: 28870863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.